Humana Inc. (NYSE:HUM) Receives $297.58 Consensus Target Price from Analysts

Shares of Humana Inc. (NYSE:HUM) have received a consensus rating of “Hold” from the nineteen research firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $299.2222.

Several research firms have issued reports on HUM. Sanford C. Bernstein raised their target price on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Wall Street Zen cut Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. The Goldman Sachs Group initiated coverage on Humana in a research note on Tuesday, October 14th. They set a “sell” rating and a $235.00 target price for the company. Finally, Robert W. Baird cut their target price on Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a research note on Friday, July 25th.

Institutional Investors Weigh In On Humana

Institutional investors have recently modified their holdings of the company. Cary Street Partners Investment Advisory LLC grew its stake in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after buying an additional 46 shares in the last quarter. Elevation Point Wealth Partners LLC acquired a new stake in shares of Humana in the second quarter valued at $32,000. Mather Group LLC. acquired a new stake in shares of Humana in the third quarter valued at $34,000. Zions Bancorporation National Association UT acquired a new stake in shares of Humana in the first quarter valued at $37,000. Finally, Private Wealth Management Group LLC grew its stake in shares of Humana by 47.5% in the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after buying an additional 48 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Price Performance

NYSE:HUM opened at $280.19 on Friday. Humana has a one year low of $206.87 and a one year high of $315.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a market cap of $33.70 billion, a PE ratio of 21.50, a P/E/G ratio of 1.71 and a beta of 0.42. The stock has a 50 day moving average price of $280.99 and a 200 day moving average price of $258.73.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.